Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

By Yonemori Kan   Katsumata Noriyuki   Uno Hajime   Matsumoto Koji   Kouno Tsutomu   Tokunaga Shinya   Yamanaka Yasuhiro   Shimizu Chikako   Ando Masashi   Takeuchi Masahiro   Fujiwara Yasuhiro  

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 237-241

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and feasibility of neoadjuvant chemotherapy with FEC 100 followed by weekly paclitaxel for operable breast cancer

By                

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 612-616

Spandidos Publications

Access to resources Recommend Favorite

First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study

By Aogi Kenjiro   Masuda Norikazu   Ohno Shinji   Oda Takashi   Iwata Hiroji   Kashiwaba Masahiro   Fujiwara Yasuhiro   Kamigaki Shunji   Ito Yoshinori   Ueno Takayuki   Takashima Shigemitsu  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 829-838

Springer Publishing Company

Access to resources Recommend Favorite

Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy

By Shayne Michelle   Crawford Jeffrey   Dale David   Culakova Eva   Lyman Gary  

Breast Cancer Research and Treatment, Vol. 100, Iss. 3, 2006-12 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite

Weekly Paclitaxel in Women Age 65 and Above with Metastatic Breast Cancer*

By Perez E.A.  

Breast Cancer Research and Treatment, Vol. 73, Iss. 1, 2002-05 ,pp. : 85-88

Springer Publishing Company

Access to resources Recommend Favorite